2ʹ-O-(2-Methoxyethyl) Antisense Oligonucleotide Targeting Microtubule-Associated Protein Tau Pre-Mrna

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

11 Countries

Phase II

Phase II: 2

Sponsors using this IMP

Biogen Idec Research Limited 2

All trials

2 total

A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised

2022-501644-15-00 Phase II 11 countries Biogen Idec Research Limited
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended

2022-501644-15-01 Phase II 11 countries Biogen Idec Research Limited

Showing 1–2 of 2 trials

← All drugs A–Z